TRIM21 and myositis disease: A striking feature was a strongly increased interferon signature (4124 [Ref.-range: <12.49]) (see Fig. 3) and positive myositis-specific MDA5 alongside myositis-associated Ro52 autoantibodies (for detailed information about the measurement of the interferone signature, please see the supplementary material).